ID: ALA5082531

Max Phase: Preclinical

Molecular Formula: C12H11Cl2NO2

Molecular Weight: 272.13

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  C=CCN(O)C(=O)/C=C/c1ccc(Cl)cc1Cl

Standard InChI:  InChI=1S/C12H11Cl2NO2/c1-2-7-15(17)12(16)6-4-9-3-5-10(13)8-11(9)14/h2-6,8,17H,1,7H2/b6-4+

Standard InChI Key:  LSMBWWWRPMSLJN-GQCTYLIASA-N

Associated Targets(non-human)

Botulinum neurotoxin type A 1303 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 272.13Molecular Weight (Monoisotopic): 271.0167AlogP: 3.41#Rotatable Bonds: 4
Polar Surface Area: 40.54Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.54CX Basic pKa: CX LogP: 3.49CX LogD: 3.46
Aromatic Rings: 1Heavy Atoms: 17QED Weighted: 0.39Np Likeness Score: -0.92

References

1. Patel EN, Turner LD, Hixon MS, Janda KD..  (2022)  Identification of Slow-Binding Inhibitors of the BoNT/A Protease.,  13  (4.0): [PMID:35450355] [10.1021/acsmedchemlett.2c00028]

Source